Steroids After Laser Trabeculoplasty for Glaucoma

• Status: Completed
• Trial end date: 2015-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether the choice of post-operative eye drop administered after selective laser trabeculoplasty (SLT) for glaucoma affects the efficacy in lowering intraocular pressure (IOP).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Stanford University
• Collaborators: Bascom Palmer Eye Institute; University of Pittsburgh; University of Pittsburgh Medical Center
• Treatments: Anti-Inflammatory Agents; Diclofenac; Ketorolac; Lubricant Eye Drops; Methylprednisolone; Methylprednisolone acetate; Methylprednisolone Hemisuccinate; Prednisolone; Prednisolone acetate; Prednisolone hemisuccinate; Prednisolone phosphate

Criteria

Inclusion Criteria:

• clinical diagnosis of glaucoma

• clinician has determined that SLT laser is indicated

• IOP currently >18 and was ever >21 in the past (e.g. prior to treatment)

Exclusion Criteria:

• prior history of uveitis

• prior glaucoma surgery including glaucoma laser surgery

• pregnant or 3 months post-partum